MOSCOW, October 6. /TASS/. Nearly 30,000 volunteers will take part in post-registration trials of the coronavirus vaccine developed by Russia's Vector State Research Center of Virology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback